The development of new capillary networks appears to be necessary for the growth of solid tumors. Tumor angiogenesis is believed to be mediated by soluble factors released from tumor cells that then act on endothelial cells in a paracrine manner. Vascular endothelial growth factor (VEGF) is a prime regulator of normal and tumor angiogenesis as well as vasculogenesis. VEGF is expressed in glioma cells and its receptors (Flt-1 and KDR) are expressed in the same gliomas. The two receptors are tyrosine kinases and have an extracellular domain containing seven immunoglobulin-like loops and a split tyrosine-kinase domain. KDR is a receptor for the various VEGF isoforms and for VEGF-C; Flt-1 is a receptor for the various isoforms. Studies suggest that the VEGF receptors are induced in endothelial cells during tumor angiogenesis. Stimulation of aortic endothelial cells results in receptor tyrosine phosphorylation (receptor activation). In this study the activation state of the KDR receptors was determined in low grade, anaplastic, and high grade gliomas.
|Titolo:||KDR activation in astrocytic neoplasms|
|Parole Chiave:||Vascular Endothelial Growth Factor A; Glioblastoma; Astrocytoma; Receptors, Growth Factor; Humans; Disease Progression; Endothelial Growth Factors; Protein Isoforms; Receptors, Vascular Endothelial Growth Factor; Receptor Protein-Tyrosine Kinases; Brain Neoplasms; Antibodies; Blotting, Western; Phosphorylation; Vascular Endothelial Growth Factors; Neovascularization, Pathologic; Lymphokines; Cell Line; Female; Male|
|Settore Scientifico Disciplinare:||Settore MED/27 - Neurochirurgia|
|Data di pubblicazione:||1-ott-1999|
|Digital Object Identifier (DOI):||10.1002/(SICI)1097-0142(19991001)86:7<1335::AID-CNCR32>3.0.CO;2-Z|
|Appare nelle tipologie:||01 - Articolo su periodico|